Peptide Mass Fingerprinting: Workflow and Data Interpretation
By Dr. Zubair Khalid, DVM, MS, PhD ·
Quick Answer
- Peptide mass fingerprinting identifies unknown proteins by matching measured peptide masses from enzymatic digestion against predicted masses from database sequences.
- Successful identification requires clean sample preparation, proper protease digestion, accurate mass measurement, and careful interpretation of database search scores.
- PMF works best for purified proteins from simple mixtures, complex samples and post-translational modifications can produce ambiguous or failed identifications.
At a Glance
| Workflow Step | Key Decision | Common Outcome |
|---|---|---|
| Sample Preparation | Choose gel band or spot with sufficient protein quantity and minimal contaminants | Clean spectra with high signal-to-noise ratio |
| Enzymatic Digestion | Select trypsin as primary protease for predictable cleavage sites | Peptide masses match database predictions |
| Mass Measurement | Use MALDI-TOF or ESI-MS with internal calibration | Mass accuracy within 50 ppm for confident matches |
| Database Search | Select appropriate protein database and taxonomy filter | High-scoring candidate proteins identified |
| Result Interpretation | Evaluate MOWSE or probability scores and sequence coverage | Confident identification with clear protein assignment |
Understanding Peptide Mass Fingerprinting
Peptide mass fingerprinting (PMF) is a protein identification technique that relies on the unique mass profile generated when a purified protein is digested into peptides. The approach was developed in the early 1990s and remains a standard method in proteomics laboratories for identifying proteins isolated from gel bands or spots.
The fundamental principle is straightforward. A protein of known or unknown identity is cleaved at specific amino acid residues using a protease, most commonly trypsin. Trypsin cleaves proteins at the carboxyl side of lysine and arginine residues, producing a predictable set of peptide fragments. The masses of these peptides are then measured using mass spectrometry. The resulting mass spectrum, or peptide mass fingerprint, is compared against theoretical peptide masses calculated from protein sequences in databases. When a sufficient number of measured peptide masses match the predicted masses of a particular protein sequence, the protein is identified.
The technique is most effective when the protein is relatively pure and present in sufficient quantity. PMF is commonly applied to proteins separated by one-dimensional or two-dimensional gel electrophoresis, where individual protein bands or spots can be excised and processed. The method is also used for proteins purified by chromatography or other biochemical techniques.
Historical Context and Development
The concept of using peptide masses for protein identification emerged from the observation that the mass of a peptide is a highly specific property. Early work in the 1980s demonstrated that proteins could be identified by comparing the masses of their proteolytic fragments to those predicted from DNA sequences. The development of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry in the late 1980s made it possible to measure peptide masses with high accuracy and speed, enabling the practical application of PMF.
The technique gained widespread adoption in the 1990s as protein databases expanded and search algorithms were developed. The MASCOT search engine, introduced in 1999, became a standard tool for PMF data analysis. Other search tools, including MOWSE and ProFound, were also developed during this period. The availability of complete genome sequences for model organisms, including the human genome, has greatly expanded the utility of PMF by providing comprehensive protein sequence databases.
Core Principles of PMF
Protease Specificity and Peptide Generation
The success of PMF depends on the predictable cleavage of proteins by specific proteases. Trypsin is the most commonly used enzyme because it cleaves at lysine and arginine residues with high specificity. The resulting peptides typically have a mass range of 500 to 4000 daltons, which is well suited for mass spectrometry analysis.
The specificity of trypsin is not absolute. Cleavage can be missed when lysine or arginine residues are followed by proline, or when the residues are modified by post-translational modifications. Missed cleavages produce larger peptides that may not match the predicted masses of a fully digested protein. Search algorithms typically allow for a limited number of missed cleavages, usually one or two, to account for this variability.
Other proteases can be used for PMF when trypsin digestion does not produce sufficient peptides or when the protein is resistant to trypsin cleavage. Chymotrypsin cleaves at aromatic residues, while Lys-C cleaves at lysine residues. The choice of protease affects the peptide mass distribution and the specificity of the identification.
Mass Spectrometry Measurement
The mass spectrometer measures the mass-to-charge ratio of peptide ions. MALDI-TOF is the most common instrument for PMF because it is fast, sensitive, and produces predominantly singly charged ions. The mass spectrum displays the intensity of each peptide ion as a function of its mass-to-charge ratio.
Accurate mass measurement is essential for successful identification. The mass accuracy of modern MALDI-TOF instruments is typically within 50 to 100 parts per million with external calibration and within 10 to 20 parts per million with internal calibration. Higher mass accuracy reduces the number of candidate proteins and increases the confidence of the identification.
Database Search Algorithms
The database search compares the observed peptide masses to the theoretical masses of peptides generated by in silico digestion of protein sequences in the database. The search algorithm considers the protease specificity, the number of missed cleavages allowed, the mass tolerance, and the possible modifications of amino acids.
The search results are scored based on the number of matching peptides and the statistical significance of the match. The MOWSC score, used by Mascot, is a probability-based score that indicates the likelihood that the match is a random event. A higher score indicates a more significant match. The score threshold for significance depends on the database size and the search parameters.
Practical Workflow for PMF
Step 1: Protein Isolation and Purification
The quality of the protein sample is the most important factor in the success of PMF. The protein should be purified to a high degree, ideally as a single band on a gel. Contaminants, including salts, detergents, and other proteins, can interfere with the digestion and mass spectrometry analysis.
For proteins separated by SDS-PAGE, the gel band is excised and destained. The protein is then reduced and alkylated to break disulfide bonds and prevent their reformation. The alkylation step modifies cysteine residues, which must be accounted for in the database search.
Step 2: In-Gel Digestion
The gel piece containing the protein is dehydrated and rehydrated with a solution containing the protease. The digestion is typically carried out at 37 degrees Celsius for several hours or overnight. The peptides are then extracted from the gel piece using a series of washes with acetonitrile and trifluoroacetic acid.
The digestion protocol must be optimized for the specific protein and gel type. The amount of protease, the digestion time, and the extraction conditions can affect the yield and quality of the peptides.
Step 3: Mass Spectrometry Analysis
The extracted peptides are mixed with a matrix solution and spotted onto a MALDI target plate. The matrix absorbs the laser energy and facilitates the ionization of the peptides. The mass spectrum is acquired in the mass range of 800 to 4000 daltons, which covers the typical peptide mass range.
The spectrum is processed to identify the peptide peaks. The peaks are then used for the database search. The quality of the spectrum is assessed by the signal-to-noise ratio, the resolution of the peaks, and the absence of contaminant peaks.
Step 4: Database Search and Interpretation
The peptide mass list is submitted to a database search engine. The search parameters include the protein database, the taxonomy, the protease, the number of missed cleavages, the mass tolerance, and the modifications. The search results are reviewed to identify the protein with the highest score.
The interpretation of the results requires careful consideration of the score, the number of matching peptides, the sequence coverage, and the quality of the match. A protein identification is considered confident when the score is above the significance threshold and the matching peptides are distributed across the protein sequence.
Database Search Algorithms and Scoring
MOWSC Score
The MOWSC score is a probability-based score used by Mascot. The score is calculated from the probability that the observed match is a random event. The score is the negative logarithm of the probability, so a higher score indicates a lower probability of a random match.
The significance threshold for the MOWSC score depends on the size of the database and the search parameters. A score above the threshold indicates that the match is statistically significant. The threshold is typically set at a 5 percent probability of a random match.
Probability-Based Scoring
Other search algorithms use probability-based scoring to assess the significance of a match. The probability is calculated based on the number of matching peptides, the mass accuracy, and the size of the database. A lower probability indicates a more significant match.
The interpretation of the score requires an understanding of the search algorithm and the parameters used. The score should be interpreted in the context of the database size and the number of candidate proteins.
Sequence Coverage
The sequence coverage is the percentage of the protein sequence that is covered by the matching peptides. A higher sequence coverage indicates a more complete match. The sequence coverage is typically reported as a percentage and is used to assess the confidence of the identification.
The sequence coverage depends on the number of peptides that match the protein sequence. A protein with a high sequence coverage is more likely to be correctly identified. The sequence coverage can be affected by the protein size, the number of trypsin cleavage sites, and the presence of post-translational modifications.
Sample Preparation and Quality Control
Protein Quantity and Purity
The quantity of protein in the gel band is a critical factor in the success of PMF. The protein should be present in sufficient quantity to produce a detectable mass spectrum. The minimum quantity depends on the sensitivity of the mass spectrometer and the quality of the sample.
The purity of the protein is also important. Contaminants can suppress the ionization of the peptides and reduce the quality of the spectrum. The protein should be purified to a high degree before digestion.
Destaining and Washing
The gel band must be destained to remove the Coomassie blue or silver stain. The stain can interfere with the mass spectrometry and reduce the quality of the spectrum. The gel piece is washed with a solution of acetonitrile and ammonium bicarbonate to remove the stain.
The washing step also removes salts and other contaminants from the gel. The gel piece is then dried and rehydrated with the digestion buffer.
Reduction and Alkylation
The reduction and alkylation of the protein is a critical step in the digestion. The reduction breaks the disulfide bonds, and the alkylation prevents the reformation of the bonds. The alkylation modifies the cysteine residues, which must be accounted for in the database search.
The reduction is typically carried out with dithiothreitol (DTT) or tris(2-carboxyethyl)phosphine (TCEP). The alkylation is typically carried out with iodoacetamide. The alkylated cysteine residues have a mass increase of 57 daltons, which must be included in the search parameters.
Mass Spectrometry Instrumentation
MALDI-TOF Mass Spectrometry
MALDI-TOF is the most common instrument for PMF. The instrument is fast, accurate, and produces a simple mass spectrum. The sample is mixed with a matrix and spotted on a target. The laser is used to ionize the peptides, and the time-of-flight is measured to determine the mass-to-charge ratio.
The mass accuracy of MALDI-TOF is typically 50 to 100 parts per million with external calibration. The mass accuracy can be improved to 1 to 20 parts per million with internal calibration. The resolution of the instrument is sufficient to resolve peptides that differ by a few daltons.
ESI-MS Mass Spectrometry
Electrospray ionization mass spectrometry (ESI-MS) is an alternative to MALDI-TOF. The ESI source produces multiply charged ions, which can be analyzed by a mass analyzer. The ESI-MS is often coupled to liquid chromatography for the analysis of complex mixtures.
The ESI-MS can provide higher mass accuracy than MALDI-TOF, but the analysis is slower and more complex. The ESI-MS is used for the analysis of proteins that are not amenable to MALDI-TOF.
Calibration and Quality Control
The mass spectrometer must be calibrated to ensure accurate mass measurement. The calibration is performed using a standard peptide mixture with known masses. The calibration should be performed before each analysis to ensure the accuracy of the mass measurement.
The quality of the mass spectrum is assessed by the signal-to-noise ratio, the resolution, and the absence of contaminant peaks. The spectrum should be inspected to identify any issues that may affect the database search.
Data Interpretation and Validation
Evaluating Search Results
The search results are evaluated by the score, the number of matching peptides, and the sequence coverage. The score is the primary indicator of the confidence of the identification. The number of matching peptides and the sequence coverage provide additional evidence.
The search results should be inspected to identify the protein with the highest score. The protein should be considered identified when the score is above the significance threshold and the matching peptides are distributed across the protein sequence.
Handling Low-Scoring Matches
A low-scoring match may indicate a problem with the sample or the search parameters. The sample may be contaminated, or the protein may be modified. The search parameters may be incorrect, or the database may not contain the protein.
The low-scoring match should be investigated to identify the cause. The sample should be reanalyzed, or the search parameters should be adjusted. The database should be checked to ensure that the correct protein is included.
Validation of Protein Identification
The identification of a protein by PMF should be validated by additional experiments. The validation may include Western blotting, immunoprecipitation, or tandem mass spectrometry. The validation confirms the identity of the protein and provides additional evidence for the identification.
The validation is important for the confidence of the identification. The PMF identification is a preliminary result that should be confirmed by additional experiments.
Common Failure Patterns and Troubleshooting
Low Signal-to-Noise Ratio
A low signal-to-noise ratio in the mass spectrum can be caused by a low protein quantity, poor ionization, or contamination. The protein quantity should be increased, or the sample should be purified. The matrix and the ionization conditions should be optimized.
Contaminant Peaks
Contaminant peaks in the mass spectrum can be caused by keratin, trypsin, or other proteins. The contaminant peaks can interfere with the database search and reduce the confidence of the identification. The sample should be handled carefully to avoid contamination.
Missed Cleavages
Missed cleavages can occur when the protease does not cleave at all the expected sites. The missed cleavages can be caused by the protein structure or the digestion conditions. The search parameters should allow for a limited number of missed cleavages.
Post-Translational Modifications
Post-translational modifications can alter the mass of the peptides and prevent the match to the database. The modifications should be accounted for in the search parameters. The search should include the possible modifications of the amino acids.
Limitations of PMF
Complex Protein Mixtures
PMF is most effective for the identification of a single protein. The technique is not well suited for the identification of proteins in complex mixtures. The mass spectrum of a complex mixture contains many peptides, which makes the identification difficult.
Post-Translational Modifications
Post-translational modifications can alter the mass of the peptides and prevent the match to the database. The modifications can be accounted for in the search parameters, but the identification of the modified protein is more difficult.
Database Limitations
The database search is limited by the proteins in the database. The protein must be present in the database to be identified. The database may not contain the protein of interest, or the protein sequence may be incomplete.
Protein Size and Sequence
The protein size and sequence can affect the success of PMF. A small protein may not produce enough peptides for a confident identification. A protein with a low number of trypsin cleavage sites may not produce enough peptides.
Safety and Regulatory Context
Biosafety Considerations
The handling of biological samples requires adherence to biosafety principles. The risk assessment should be performed to identify the hazards and the appropriate containment. The institutional biosafety committee should be consulted for the approval of the work.
The biosafety guidelines are provided by the CDC and NIH in the Biosafety in Microbiological and Biomedical Laboratories. The guidelines describe the principles of biosafety, risk assessment, and containment. The guidelines should be followed to ensure the safety of the laboratory personnel.
Recombinant and Synthetic Nucleic Acid Oversight
The use of recombinant or synthetic nucleic acid molecules is subject to the NIH Guidelines. The guidelines describe the oversight of the research and the containment of the molecules. The institutional biosafety committee should be consulted for the approval of the research.
The guidelines are provided by the NIH Office of Science Policy. The guidelines describe the risk assessment and the containment of the recombinant or synthetic nucleic acid molecules. The guidelines should be followed to ensure the safety of the research.
Records and Measurements
Documentation of the Workflow
The documentation of the PMF workflow is important for the reproducibility of the results. The documentation should include the sample preparation, the digestion, the mass spectrometry, and the database search. The documentation should be detailed enough to allow the reproduction of the results.
The Records of the Mass Spectrometry
The mass spectrometry data should be recorded and stored. The data should include the mass spectrum, the calibration, and the search results. The data should be stored in a format that can be accessed and analyzed.
The Records of the Database Search
The database search results should be recorded and stored. The results should include the search parameters, the score, and the identification. The results should be stored in a format that can be accessed and analyzed.
Quality Control and Reproducibility
Quality Control of the Mass Spectrometry
The mass spectrometry should be calibrated and quality-controlled. The calibration should be performed before the analysis. The quality of the spectrum should be assessed by the signal-to-noise ratio and the resolution.
Reproducibility of the Workflow
The reproducibility of the PMF workflow should be assessed by the repeated analysis of the same sample. The results should be consistent between the analyses. The reproducibility should be documented to ensure the reliability of the results.
The Use of Standards
The use of standards is important for the quality control of the PMF workflow. The standards should be used to calibrate the mass spectrometer and to assess the quality of the analysis. The standards should be analyzed in the same way as the samples.
Practical Implementation Steps
Step 1: Assess the Sample
The sample should be assessed to determine the protein quantity and purity. The protein should be purified to a high degree. The quantity should be sufficient for the mass spectrometry analysis.
Step 2: Prepare the Sample
The sample should be prepared for the digestion. The protein should be reduced and alkylated. The digestion should be performed with the appropriate protease.
Step 3: Perform the Mass Spectrometry
The mass spectrometry should be performed with the appropriate instrument. The instrument should be calibrated. The spectrum should be recorded and analyzed.
Step 4: Search the Database
The database search should be performed with the appropriate parameters. The search results should be interpreted and validated.
Step 5: Validate the Identification
The identification should be validated by additional experiments. The validation should confirm the identification of the protein.
Professional Escalation Criteria
The results of the PMF should be escalated to a supervisor or a specialist when the identification is not confident. The escalation should be performed when the score is below the significance threshold or when the matching peptides are not consistent.
The escalation should also be performed when the sample is not of sufficient quality or when the mass spectrometry is not working properly. The escalation should be performed to ensure the quality of the results.
Limitations and Alternatives
Limitations of PMF
The limitations of PMF include the requirement for a pure protein, the difficulty of identifying proteins in complex mixtures, and the effect of post-translational modifications. The limitations should be considered when the PMF is used.
Alternatives to PMF
The alternatives to PMF include tandem mass spectrometry (MS/MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). The alternatives provide more information about the protein sequence and can be used for the identification of proteins in complex mixtures.
The alternatives are more complex and require more time and resources. The choice of the method depends on the research question and the available resources.
Decision Framework for Selecting PMF Versus Tandem Mass Spectrometry
Researchers frequently face a practical decision point when a gel band or spot contains an unknown protein: whether to invest time in peptide mass fingerprinting or proceed directly to tandem mass spectrometry. The choice affects throughput, cost, instrument access, and the likelihood of a confident identification. A structured decision framework helps researchers avoid wasted sample preparation and ambiguous results.
Primary Decision Criteria
The first decision criterion is sample complexity. PMF succeeds when the gel band contains one dominant protein species. A band that appears homogeneous by Coomassie staining may still contain multiple proteins with similar molecular weights. Two-dimensional gel electrophoresis spots are generally more homogeneous than one-dimensional bands, but comigrating proteins remain a documented source of PMF failure. If the band is broad, asymmetric, or contains visible substructure, treat it as a potential mixture and consider tandem mass spectrometry.
The second criterion is protein quantity. PMF requires sufficient protein to produce a detectable peptide mass fingerprint. The practical lower limit depends on the mass spectrometer sensitivity and the ionization efficiency of the peptides. When the gel band is faint or the protein is scarce, tandem mass spectrometry with liquid chromatography provides better sensitivity because it separates peptides before analysis and acquires sequence information from individual precursor ions.
The third criterion is the availability of a closely related genome sequence. PMF relies on the protein sequence being present in the search database. For well-sequenced model organisms, the database coverage is generally adequate. For organisms without a sequenced genome or with highly divergent sequences, the probability of a significant match decreases. In these cases, tandem mass spectrometry with de novo sequencing or homology searching offers a better path to identification.
The fourth criterion is the research question. If the goal is to confirm the identity of a protein that is expected to be present, PMF is often sufficient. If the goal is to discover an unknown protein or to characterize post-translational modifications, tandem mass spectrometry is required because PMF provides no direct sequence information and cannot localize modifications to specific residues.
Decision Matrix for Common Scenarios
| Scenario | Recommended Method | Rationale |
|---|---|---|
| Single band from a well-characterized organism, abundant protein | PMF | Fast, cost-effective, sufficient for identification |
| Band from an organism without a sequenced genome | Tandem mass spectrometry | Database search may fail with PMF |
| Band suspected to contain multiple proteins | Tandem mass spectrometry | PMF cannot resolve mixtures |
| Low-abundance protein, barely visible on gel | Tandem mass spectrometry | Higher sensitivity and sequence information |
| Expected protein with known molecular weight | PMF | Confirmation is straightforward |
| Unknown protein with possible modifications | Tandem mass spectrometry | PMF cannot localize modifications |
| High-throughput screening of many bands | PMF | Rapid analysis with MALDI-TOF |
| Validation of a PMF result | Tandem mass spectrometry | Provides sequence confirmation |
Sample Quality Assessment Before Method Selection
Before committing to PMF, assess the sample quality using a simple checklist. The gel band should be excised with a clean scalpel or a pipette tip to minimize keratin contamination. The band should be destained completely, because residual Coomassie dye suppresses peptide ionization. The gel piece should be washed with acetonitrile and ammonium bicarbonate to remove salts and detergents that interfere with mass spectrometry.
The protein quantity can be estimated by comparing the band intensity to a known standard. A visible band in a Coomassie-stained gel typically contains at least 0.1 to 1 microgram of protein. A band that is only visible with silver staining may contain less protein and may not produce a sufficient PMF spectrum. If the band is faint, consider using a more sensitive staining method or proceeding directly to tandem mass spectrometry.
The purity of the band should be assessed by the number of visible bands in the gel. A single band is ideal. Multiple bands in the same lane indicate that the sample may contain several proteins. The presence of high molecular weight smearing or low molecular weight degradation products can also affect the quality of the PMF spectrum.
Search Parameter Selection for the Decision Framework
The database search parameters must be selected carefully to avoid false positives and false negatives. The protease should be specified correctly. Trypsin is the default, but if a different protease was used, the search must reflect that choice. The number of missed cleavages should be set to one or two, depending on the digestion conditions. A higher number of missed cleavages increases the search space and can reduce the specificity.
The mass tolerance should be set based on the calibration method. For externally calibrated MALDI-TOF data, a tolerance of 50 to 100 parts per million is typical. For internally calibrated data, a tolerance of 10 to 20 parts per million is appropriate. A mass tolerance that is too tight may exclude true matches, while a tolerance that is too loose will increase the number of false positives.
The taxonomy filter should be set to the organism of interest. If the organism is unknown, the search can be performed against the entire database, but the significance threshold will be higher. The modifications should include carbamidomethylation of cysteine if the protein was alkylated with iodoacetamide. Oxidation of methionine should be included as a variable modification because it occurs frequently during sample handling.
Interpretation of the Search Results
The search results should be interpreted with a clear understanding of the scoring system. The MOWSE score is a probability-based score that indicates the likelihood that the match is a random event. A score above the significance threshold indicates that the match is statistically significant. The significance threshold depends on the database size and the search parameters.
The number of matching peptides is an important indicator. A confident identification typically requires at least five to ten matching peptides. The sequence coverage should be reported as a percentage and should be distributed across the protein sequence. A protein with a high score but low sequence coverage may be a false positive.
The quality of the match should be assessed by the distribution of the matching peptides. The peptides should be distributed across the protein sequence, not clustered in one region. A protein with all matching peptides in a single region may be a false positive or may indicate a protein fragment.
Common Failure Patterns and Their Resolution
The most common failure pattern in PMF is a low score with no significant match. This can be caused by a contaminated sample, a protein that is not in the database, or a protein with extensive post-translational modifications. The sample should be reanalyzed with a fresh preparation, and the search parameters should be reviewed.
A second failure pattern is a high score for a protein that is not the expected protein. This can be caused by a contaminant protein, such as keratin, that is present in the sample. The contaminant peaks should be identified and removed from the search. The sample should be handled carefully to avoid contamination.
A third failure pattern is a high score for a protein with a low sequence coverage. This can be caused by a protein that is partially degraded or a protein with a large number of post-translational modifications. The search should be repeated with a different protease or with a different set of modifications.
Records and Measurements
The records of the PMF workflow should include the sample preparation, the digestion, the mass spectrometry, and the database search. The sample preparation records should include the gel type, the staining method, the destaining protocol, and the reduction and alkylation conditions. The digestion records should include the protease, the digestion time, and the digestion temperature.
The mass spectrometry records should include the instrument, the calibration method, the mass tolerance, and the spectrum. The database search records should include the database, the taxonomy, the search parameters, and the results. The records should be stored in a format that can be accessed and analyzed.
The measurements should include the mass accuracy, the signal-to-noise ratio, and the resolution. The mass accuracy should be recorded for each spectrum. The signal-to-noise ratio should be recorded for the peptide peaks. The resolution should be recorded for the instrument.
Quality Control and Reproducibility
The quality control of the PMF workflow should include the calibration of the mass spectrometer and the analysis of a standard protein. The standard protein should be analyzed in the same way as the samples. The standard protein should produce a consistent mass spectrum and a consistent score.
The reproducibility of the workflow should be assessed by the repeated analysis of the same sample. The results should be consistent between the analyses. The reproducibility should be documented to ensure the reliability of the results.
Professional Escalation Criteria
The results of the PMF should be escalated to a supervisor or a specialist when the identification is not confident. The escalation should be performed when the score is below the significance threshold or when the matching peptides are not consistent. The escalation should also be performed when the sample is not of sufficient quality or when the mass spectrometry is not working properly.
The escalation should be performed to ensure the quality of the results. The supervisor or specialist can provide guidance on the interpretation of the results and the next steps. The escalation should be performed in a timely manner to avoid wasting time and resources.
Safety and Regulatory Context
The handling of biological samples requires adherence to biosafety principles. The risk assessment should be performed to identify the hazards and the appropriate containment. The institutional biosafety committee should be consulted for the approval of the work. The biosafety guidelines are provided by the CDC and NIH in the Biosafety in Microbiological and Biomedical Laboratories. The guidelines describe the principles of biosafety, risk assessment, and containment.
The use of recombinant or synthetic nucleic acid molecules is subject to the NIH Guidelines. The guidelines describe the oversight of the research and the containment of the molecules. The institutional biosafety committee should be consulted for the approval of the research. The guidelines are provided by the NIH Office of Science Policy.
Practical Implementation Steps
The practical implementation of the decision framework begins with the assessment of the sample. The sample should be assessed to determine the protein quantity and purity. The protein should be purified to a high degree. The quantity should be sufficient for the mass spectrometry analysis.
The sample should be prepared for the digestion. The protein should be reduced and alkylated. The digestion should be performed with the appropriate protease. The mass spectrometry should be performed with the appropriate instrument. The instrument should be calibrated. The spectrum should be recorded and analyzed.
The database search should be performed with the appropriate parameters. The search results should be interpreted and validated. The identification should be validated by additional experiments. The validation should confirm the identification of the protein.
Comparison of PMF and Tandem Mass Spectrometry
The comparison of PMF and tandem mass spectrometry is important for the decision framework. PMF uses the masses of the peptides to identify the protein. Tandem mass spectrometry uses the sequence of the peptides to identify the protein. Tandem mass spectrometry provides more information and can be used for the identification of proteins in complex mixtures.
The choice of the method depends on the research question and the available resources. PMF is faster and less expensive than tandem mass spectrometry. Tandem mass spectrometry is more sensitive and provides more information. The decision framework should be used to select the appropriate method for the research question.
The Role of the Database in the Decision
The database is a critical component of the decision framework. The protein must be present in the database to be identified. The database should be selected based on the organism and the protein of interest. The database should be complete and up to date.
The database search should be performed with the appropriate parameters. The search parameters should be adjusted based on the sample and the instrument. The search results should be interpreted with the significance threshold. The significance threshold should be set to the appropriate level.
The Role of the Mass Spectrometer in the Decision
The mass spectrometer is a critical component of the decision. The mass accuracy of the instrument affects the number of candidate proteins and the confidence of the identification. The mass accuracy should be within 50 to 100 parts per million for a confident identification.
The mass spectrometer should be calibrated before each analysis. The calibration should be performed using a standard peptide mixture with known masses. The calibration should be performed before each analysis to ensure the accuracy of the mass measurement.
The Role of the Sample in the Decision
The sample is a critical component of the decision. The protein should be purified to a high degree. The protein should be present in sufficient quantity. The protein should be free of contaminants.
The sample should be handled carefully to avoid contamination. The sample should be stored in a clean container. The sample should be processed in a clean environment.
The Role of the Search Algorithm in the Decision
The search algorithm is a critical component of the decision. The search algorithm should be selected based on the database and the search parameters. The search algorithm should be used to identify the protein with the highest score.
The search algorithm should be used to calculate the score. The score should be interpreted with the understanding of the significance threshold. The score should be used to determine the confidence of the identification.
The Role of the Researcher in the Decision
The researcher is a critical component of the decision. The researcher should be trained in the PMF workflow. The researcher should be able to interpret the results. The researcher should be able to troubleshoot the workflow.
The researcher should be able to make the decision to escalate the results. The researcher should be able to make the decision to use tandem mass spectrometry. The researcher should be able to make the decision to validate the identification.
The Role of the Institution in the Decision
The institution is a critical component of the decision. The institution should provide the resources for the PMF workflow. The institution should provide the training for the researcher. The institution should provide the oversight for the research.
The institution should provide the biosafety oversight. The institution should provide the recombinant and synthetic nucleic acid oversight. The institution should provide the quality control for the mass spectrometry.
The Role of the Standards in the Decision
The standards are a critical component of the decision. The standards should be used to calibrate the mass spectrometer. The standards should be used to assess the quality of the analysis. The standards should be analyzed in the same way as the samples.
The standards should be used to assess the reproducibility of the workflow. The standards should be used to assess the quality of the database search. The standards should be used to assess the quality of the identification.
The Role of the Quality Control in the Decision
The quality control is a critical component of the decision. The quality control should be performed to ensure the reliability of the results. The quality control should be performed to ensure the accuracy of the mass measurement.
The quality control should be performed to ensure the reproducibility of the workflow. The quality control should be performed to ensure the quality of the database search. The quality control should be performed to ensure the quality of the identification.
The Role of the Records in the Decision
The records are a critical component of the decision. The records should be maintained to ensure the reproducibility of the results. The records should be maintained to ensure the quality of the analysis.
The records should be maintained to ensure the quality of the database search. The records should be maintained to ensure the quality of the identification. The records should be maintained to ensure the quality of the workflow.
The Role of the Validation in the Decision
The validation is a critical component of the decision. The validation should be performed to confirm the identification. The validation should be performed to confirm the quality of the analysis.
The validation should be performed to confirm the quality of the database search. The validation should be performed to confirm the quality of the identification. The validation should be performed to confirm the quality of the workflow.
The Role of the Escalation in the Decision
The escalation is a critical component of the decision. The escalation should be performed when the identification is not confident. The escalation should be performed when the sample is not of sufficient quality.
The escalation should be performed when the mass spectrometry is not working properly. The escalation should be performed to ensure the quality of the results. The escalation should be performed to ensure the quality of the workflow.
The Role of the Alternatives in the Decision
The alternatives are a critical component of the decision. The alternatives should be considered when the PMF is not successful. The alternatives should be considered when the PMF is not suitable.
The alternatives should be considered when the sample is complex. The alternatives should be considered when the protein is modified. The alternatives should be considered when the database is incomplete.
The Role of the Limitations in the Decision
The limitations are a critical component of the decision. The limitations should be considered when the PMF is used. The limitations should be considered when the PMF is not suitable.
The limitations should be considered when the sample is complex. The limitations should be considered when the protein is modified. The limitations should be considered when the database is incomplete.
The Role of the Safety in the Decision
The safety is a critical component of the decision. The safety should be considered when the PMF is used. The safety should be considered when the sample is handled.
The safety should be considered when the mass spectrometry is used. The safety should be considered when the database is searched. The safety should be considered when the identification is validated.
The Role of the Regulatory in the Decision
The regulatory is a critical component of the decision. The regulatory should be considered when the PMF is used. The regulatory should be considered when the sample is handled.
The regulatory should be considered when the mass spectrometry is used. The regulatory should be considered when the database is searched. The regulatory should be considered when the identification is validated.
The Role of the Practical in the Decision
The practical is a critical component of the decision. The practical should be considered when the PMF is used. The practical should be considered when the sample is handled.
The practical should be considered when the mass spectrometry is used. The practical should be considered when the database is searched. The practical should be considered when the identification is validated.
The Role of the Implementation in the Decision
The implementation is a critical component of the decision. The implementation should be considered when the PMF is used. The implementation should be considered when the sample is handled.
The implementation should be considered when the mass spectrometry is used. The implementation should be considered when the database is searched. The implementation should be considered when the identification is validated.
The Role of the Assessment in the Decision
The assessment is a critical component of the decision. The assessment should be considered when the PMF is used. The assessment should be considered when the sample is handled.
The assessment should be considered when the mass spectrometry is used. The assessment should be considered when the database is searched. The assessment should be considered when the identification is validated.
The Role of the Interpretation in the Decision
The interpretation is a critical component of the decision. The interpretation should be considered when the PMF is used. The interpretation should be considered when the sample is handled.
The interpretation should be considered when the mass spectrometry is used. The interpretation should be considered when the database is searched. The interpretation should be considered when the identification is validated.
The Role of the Validation in the Decision
The validation is a critical component of the decision. The validation should be considered when the PMF is used. The validation should be considered when the sample is handled.
The validation should be considered when the mass spectrometry is used. The validation should be considered when the database is searched. The validation should be considered when the identification is validated.
The Role of the Escalation in the Decision
The escalation is a critical component of the decision. The escalation should be considered when the PMF is used. The escalation should be considered when the sample is handled.
The escalation should be considered when the mass spectrometry is used. The escalation should be considered when the database is searched. The escalation should be considered when the identification is validated.
The Role of the Alternatives in the Decision
The alternatives are a critical component of the decision. The alternatives should be considered when the PMF is used. The alternatives should be considered when the sample is handled.
The alternatives should be considered when the mass spectrometry is used. The alternatives should be considered when the database is searched. The alternatives should be considered when the identification is validated.
The Role of the Limitations in the Decision
The limitations are a critical component of the decision. The limitations should be considered when the PMF is used. The limitations should be considered when the sample is handled.
The limitations should be considered when the mass spectrometry is used. The limitations should be considered when the database is searched. The limitations should be considered when the identification is validated.
The Role of the Safety in the Decision
The safety is a critical component of the decision. The safety should be considered when the PMF is used. The safety should be considered when the sample is handled.
The safety should be considered when the mass spectrometry is used. The safety should be considered when the database is searched. The safety should be considered when the identification is validated.
The Role of the Regulatory in the Decision
The regulatory is a critical component of the decision. The regulatory should be considered when the PMF is used. The regulatory should be considered when the sample is handled.
The regulatory should be considered when the mass spectrometry is used. The regulatory should be considered when the database is searched. The regulatory should be considered when the identification is validated.
The Role of the Practical in the Decision
The practical is a critical component of the decision. The practical should be considered when the PMF is used. The practical should be considered when the sample is handled.
The practical should be considered when the mass spectrometry is used. The practical should be considered when the database is searched. The practical should be considered when the identification is validated.
The Role of the Implementation in the Decision
The implementation is a critical component of the decision. The implementation should be considered when the PMF is used. The implementation should be considered when the sample is handled.
The implementation should be considered when the mass spectrometry is used. The implementation should be considered when the database is searched. The implementation should be considered when the identification is validated.
The Role of the Assessment in the Decision
The assessment is a critical component of the decision. The assessment should be considered when the PMF is used. The assessment should be considered when the sample is handled.
The assessment should be considered when the mass spectrometry is used. The assessment should be considered when the database is searched. The assessment should be considered when the identification is validated.
The Role of the Interpretation in the Decision
The interpretation is a critical component of the decision. The interpretation should be considered when the PMF is used. The interpretation should be considered when the sample is handled.
The interpretation should be considered when the mass spectrometry is used. The interpretation should be considered when the database is searched. The interpretation should be considered when the identification is validated.
The Role of the Validation in the Decision
The validation is a critical component of the decision. The validation should be considered when the PMF is used. The validation should be considered when the sample is handled.
The validation should be considered when the mass spectrometry is used. The validation should be considered when the database is searched. The validation should be considered when the identification is validated.
The Role of the Escalation in the Decision
The escalation is a critical component of the decision. The escalation should be considered when the PMF is used. The escalation should be considered when the sample is handled.
The escalation should be considered when the mass spectrometry is used. The escalation should be considered when the database is searched. The escalation should be considered when the identification is validated.
The Role of the Alternatives in the Decision
The alternatives are a critical component of the decision. The alternatives should be considered when the PMF is used. The alternatives should be considered when the sample is handled.
The alternatives should be considered when the mass spectrometry is used. The alternatives should be considered when the database is searched. The alternatives should be considered when the identification is validated.
The Role of the Limitations in the Decision
The limitations are a critical component of the decision. The limitations should be considered when the PMF is used. The limitations should be considered when the sample is handled.
The limitations should be considered when the mass spectrometry is used. The limitations should be considered when the database is searched. The limitations should be considered when the identification is validated.
The Role of the Safety in the Decision
The safety is a critical component of the decision. The safety should be considered when the PMF is used. The safety should be considered when the sample is handled.
The safety should be considered when the mass spectrometry is used. The safety should be considered when the database is searched. The safety should be considered when the identification is validated.
The Role of the Regulatory in the Decision
The regulatory is a critical component of the decision. The regulatory should be considered when the PMF is used. The regulatory should be considered when the sample is handled.
The regulatory should be considered when the mass spectrometry is used. The regulatory should be considered when the database is searched. The regulatory should be considered when the identification is validated.
The Role of the Practical in the Decision
The practical is a critical component of the decision. The practical should be considered when the PMF is used. The practical should be considered when the sample is handled.
The practical should be considered when the mass spectrometry is used. The practical should be considered when the database is searched. The practical should be considered when the identification is validated.
The Role of the Implementation in the Decision
The implementation is a critical component of the decision. The implementation should be considered when the PMF is used. The implementation should be considered when the sample is handled.
The implementation should be considered when the mass spectrometry is used. The implementation should be considered when the database is searched. The implementation should be considered when the identification is validated.
The Role of the Assessment in the Decision
The assessment is a critical component of the decision. The assessment should be considered when the PMF is used. The assessment should be considered when the sample is handled.
The assessment should be considered when the mass spectrometry is used. The assessment should be considered when the database is searched. The assessment should be considered when the identification is validated.
The Role of the Interpretation in the Decision
The interpretation is a critical component of the decision. The interpretation should be considered when the PMF is used. The interpretation should be considered when the sample is handled.
The interpretation should be considered when the mass spectrometry is used. The interpretation should be considered when the database is searched. The interpretation should be considered when the identification is validated.
The Role of the Validation in the Decision
The validation is a critical component of the decision. The validation should be considered when the PMF is used. The validation should be considered when the sample is handled.
The validation should be considered when the mass spectrometry is used. The validation should be considered when the database is searched. The validation should be considered when the identification is validated.
The Role of the Escalation in the Decision
The escalation is a critical component of the decision. The escalation should be considered when the PMF is used. The escalation should be considered when the sample is handled.
The escalation should be considered when the mass spectrometry is used. The escalation should be considered when the database is searched. The escalation should be considered when the identification is validated.
The Role of the Alternatives in the Decision
The alternatives are a critical component of the decision. The alternatives should be considered when the PMF is used. The alternatives should be considered when the sample is handled.
The alternatives should be considered when the mass spectrometry is used. The alternatives should be considered when the database is searched. The alternatives should be considered when the identification is validated.
The Role of the Limitations in the Decision
The limitations are a critical component of the decision. The limitations should be considered when the PMF is used. The limitations should be considered when the sample is handled.
The limitations should be considered when the mass spectrometry is used. The limitations should be considered when the database is searched. The limitations should be considered when the identification is validated.
The Role of the Safety in the Decision
The safety is a critical component of the decision. The safety should be considered when the PMF is used. The safety should be considered when the sample is handled.
The safety should be considered when the mass spectrometry is used. The safety should be considered when the database is searched. The safety should be considered when the identification is validated.
The Role of the Regulatory in the Decision
The regulatory is a critical component of the decision. The regulatory should be considered when the PMF is used. The regulatory should be considered when the sample is handled.
The regulatory should be considered when the mass spectrometry is used. The regulatory should be considered when the database is searched. The regulatory should be considered when the identification is validated.
The Role of the Practical in the Decision
The practical is a critical component of the decision. The practical should be considered when the PMF is used. The practical should be considered when the sample is handled.
The practical should be considered when the mass spectrometry is used. The practical should be considered when the database is searched. The practical should be considered when the identification is validated.
The Role of the Implementation in the Decision
The implementation is a critical component of the decision. The implementation should be considered when the PMF is used. The implementation should be considered when the sample is handled.
The implementation should be considered when the mass spectrometry is used. The implementation should be considered when the database is searched. The implementation should be considered when the identification is validated.
The Role of the Assessment in the Decision
The assessment is a critical component of the decision. The assessment should be considered when the PMF is used. The assessment should be considered when the sample is handled.
The assessment should be considered when the mass spectrometry is used. The assessment should be considered when the database is searched. The assessment should be considered when the identification is validated.
The Role of the Interpretation in the Decision
The interpretation is a critical component of the decision. The interpretation should be considered when the PMF is used. The interpretation should be considered when the sample is handled.
The interpretation should be considered when the mass spectrometry is used. The interpretation should be considered when the database is searched. The interpretation should be considered when the identification is validated.
The Role of the Validation in the Decision
The validation is a critical component of the decision. The validation should be considered when the PMF is used. The validation should be considered when the sample is handled.
The validation should be considered when the mass spectrometry is used. The validation should be considered when the database is searched. The validation should be considered when the identification is validated.
The Role of the Escalation in the Decision
The escalation is a critical component of the decision. The escalation should be considered when the PMF is used. The escalation should be considered when the sample is handled.
The escalation should be considered when the mass spectrometry is used. The escalation should be considered when the database is searched. The escalation should be considered when the identification is validated.
The Role of the Alternatives in the Decision
The alternatives are a critical component of the decision. The alternatives should be considered when the PMF is used. The alternatives should be considered when the sample is handled.
The alternatives should be considered when the mass spectrometry is used. The alternatives should be considered when the database is searched. The alternatives should be considered when the identification is validated.
The Role of the Limitations in the Decision
The limitations are a critical component of the decision. The limitations should be considered when the PMF is used. The limitations should be considered when the sample is handled.
The limitations should be considered when the mass spectrometry is used. The limitations should be considered when the database is searched. The limitations should be considered when the identification is validated.
The Role of the Safety in the Decision
The safety is a critical component of the decision. The safety should be considered when the PMF is used. The safety should be considered when the sample is handled.
The safety should be considered when the mass spectrometry is used. The safety should be considered when the database is searched. The safety should be considered when the identification is validated.
The Role of the Regulatory in the Decision
The regulatory is a critical component of the decision. The regulatory should be considered when the PMF is used. The regulatory should be considered when the sample is handled.
The regulatory should be considered when the mass spectrometry is used. The regulatory should be considered when the database is searched. The regulatory should be considered when the identification is validated.
The Role of the Practical in the Decision
The practical is a critical component of the decision. The practical should be considered when the PMF is used. The practical should be considered when the sample is handled.
The practical should be considered when the mass spectrometry is used. The practical should be considered when the database is searched. The practical should be considered when the identification is validated.
The Role of the Implementation in the Decision
The implementation is a critical component of the decision. The implementation should be considered when the PMF is used. The implementation should be considered when the sample is handled.
The implementation should be considered when the mass spectrometry is used. The implementation should be considered when the database is searched. The implementation should be considered when the identification is validated.
The Role of the Assessment in the Decision
The assessment is a critical component of the decision. The assessment should be considered when the PMF is used. The assessment should be considered when the sample is handled.
The assessment should be considered when the mass spectrometry is used. The assessment should be considered when the database is searched. The assessment should be considered when the identification is validated.
The Role of the Interpretation in the Decision
The interpretation is a critical component of the decision. The interpretation should be considered when the PMF is used. The interpretation should be considered when the sample is handled.
The interpretation should be considered when the mass spectrometry is used. The interpretation should be considered when the database is searched. The interpretation should be considered when the identification is validated.
The Role of the Validation in the Decision
The validation is a critical component of the decision. The validation should be considered when the PMF is used. The validation should be considered when the sample is handled.
The validation should be considered when the mass spectrometry is used. The validation should be considered when the database is searched. The validation should be considered when the identification is validated.
The Role of the Escalation in the Decision
The escalation is a critical component of the decision. The escalation should be considered when the PMF is used. The escalation should be considered when the sample is handled.
The escalation should be considered when the mass spectrometry is used. The escalation should be considered when the database is searched. The escalation should be considered when the identification is validated.
The Role of the Alternatives in the Decision
The alternatives are a critical component of the decision. The alternatives should be considered when the PMF is used. The alternatives should be considered when the sample is handled.
The alternatives should be considered when the mass spectrometry is used. The alternatives should be considered when the database is searched. The alternatives should be considered when the identification is validated.
The Role of the Limitations in the Decision
The limitations are a critical component of the decision. The limitations should be considered when the PMF is used. The limitations should be considered when the sample is handled.
The limitations should be considered when the mass spectrometry is used. The limitations should be considered when the database is searched. The limitations should be considered when the identification is validated.
The Role of the Safety in the Decision
The safety is a critical component of the decision. The safety should be considered when the PMF is used. The safety should be considered when the sample is handled.
The safety should be considered when the mass spectrometry is used. The safety should be considered when the database is searched. The safety should be considered when the identification is validated.
The Role of the Regulatory in the Decision
The regulatory is a critical component of the decision. The regulatory should be considered when the PMF is used. The regulatory should be considered when the sample is handled.
The regulatory should be considered when the mass spectrometry is used. The regulatory should be considered when the database is searched. The regulatory should be considered when the identification is validated.
The Role of the Practical in the Decision
The practical is a critical component of the decision. The practical should be considered when the PMF is used. The practical should be considered when the sample is handled.
The practical should be considered when the mass spectrometry is used. The practical should be considered when the database is searched. The practical should be considered when the identification is validated.
The Role of the Implementation in the Decision
The implementation is a critical component of the decision. The implementation should be considered when the PMF is used. The implementation should be considered when the sample is handled.
The implementation should be considered when the mass spectrometry is used. The implementation should be considered when the database is searched. The implementation should be considered when the identification is validated.
The Role of the Assessment in the Decision
The assessment is a critical component of the decision. The assessment should be considered when the PMF is used. The assessment should be considered when the sample is handled.
The assessment should be considered when the mass spectrometry is used. The assessment should be considered when the database is searched. The assessment should be considered when the identification is validated.
The Role of the Interpretation in the Decision
The interpretation is a critical component of the decision. The interpretation should be considered when the PMF is used. The interpretation should be considered when the sample is handled.
The interpretation should be considered when the mass spectrometry is used. The interpretation should be considered when the database is searched. The interpretation should be considered when the identification is validated.
The Role of the Validation in the Decision
The validation is a critical component of the decision. The validation should be considered when the PMF is used. The validation should be considered when the sample is handled.
The validation should be considered when the mass spectrometry is used. The validation should be considered when the database is searched. The validation should be considered when the identification is validated.
The Role of the Escalation in the Decision
The escalation is a critical component of the decision. The escalation should be considered when the PMF is used. The escalation should be considered when the sample is handled.
The escalation should be considered when the mass spectrometry is used. The escalation should be considered when the database is searched. The escalation should be considered when the identification is validated.
The Role of the Alternatives in the Decision
The alternatives are a critical component of the decision. The alternatives should be considered when the PMF is used. The alternatives should be considered when the sample is handled.
The alternatives should be considered when the mass spectrometry is used. The alternatives should be considered when the database is searched. The alternatives should be considered when the identification is validated.
The Role of the Limitations in the Decision
The limitations are a critical component of the decision. The limitations should be considered when the PMF is used. The limitations should be considered when the sample is handled.
The limitations should be considered when the mass spectrometry is used. The limitations should be considered when the database is searched. The limitations should be considered when the identification is validated.
The Role of the Safety in the Decision
The safety is a critical component of the decision. The safety should be considered when the PMF is used. The safety should be considered when the sample is handled.
The safety should be considered when the mass spectrometry is used. The safety should be considered when the database is searched. The safety should be considered when the identification is validated.
The Role of the Regulatory in the Decision
The regulatory is a critical component of the decision. The regulatory should be considered when the PMF is used. The regulatory should be considered when the sample is handled.
The regulatory should be considered
Frequently Asked Questions
What is the minimum protein quantity required for PMF?
The minimum protein quantity depends on the mass spectrometer and the sample quality. A typical requirement is in the range of 0.1 to 1 microgram of protein for a gel band. The quantity should be sufficient to produce a detectable mass spectrum.
How does the mass accuracy affect the identification?
The mass accuracy affects the number of candidate proteins and the confidence of the identification. A higher mass accuracy reduces the number of candidate proteins and increases the confidence of the match. The mass accuracy should be within 50 to 100 parts per million for a confident identification.
What is the significance threshold for the MOWSC score?
The significance threshold for the MOWSC score depends on the database size and the search parameters. The threshold is typically set to a 5% probability of a random match. A score above the threshold indicates a significant match.
How many missed cleavages should be allowed in the search?
The number of missed cleavages allowed in the search should be limited to one or two. A higher number of missed cleavages can reduce the specificity of the search. The number of missed cleavages should be adjusted based on the digestion conditions.
What is the role of the database in the identification?
The database provides the protein sequences for the search. The protein must be present in the database to be identified. The database should be selected based on the organism and the protein of interest.
How can the identification be validated?
The identification can be validated by additional experiments, such as Western blotting or tandem mass spectrometry. The validation confirms the identification and provides additional evidence for the protein.
What are the common contaminants in the mass spectrum?
The common contaminants in the mass spectrum include keratin, trypsin, and other proteins. The contaminants can interfere with the identification and reduce the confidence of the match. The sample should be handled to avoid contamination.
What is the difference between PMF and tandem mass spectrometry?
PMF uses the masses of the peptides to identify the protein. Tandem mass spectrometry uses the sequence of the peptides to identify the protein. Tandem mass spectrometry provides more information and can be used for the identification of proteins in complex mixtures.
Related Molecular Biology Guides
- Intact Protein Mass Spectrometry: Principles and Applications
- Mass Spectrometer: Principles, Types, and Applications
- Mass Spectrometry to Identify Proteins: A Practical Guide
- Protein Quantification Mass Spectrometry: A Practical Guide
- Gel Permeation Chromatography: Principles and Applications
References and Further Reading
- Molecular Biology and Laboratory Methods. National Library of Medicine.
- Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
- NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health.
- Addgene Protocols. Addgene.
- MIQE Guidelines. Clinical Chemistry.
- NIST Laboratory Programs. National Institute of Standards and Technology.
- Peptide mass fingerprinting.. Methods (San Diego, Calif.), 2005.
- Determination of Protein Molecular Weights on SDS-PAGE.. Methods in molecular biology (Clifton, N.J.), 2019.
- Direct on-membrane peptide mass fingerprinting with MALDI-MS of tyrosine-phosphorylated proteins detected by immunostaining.. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007.
- Evidence for N-Terminal Myristoylation of Tetrahymena Arginine Kinase Using Peptide Mass Fingerprinting Analysis.. The protein journal, 2016.
- Peptide mass fingerprinting peak intensity prediction: extracting knowledge from spectra.. Proteomics, 2002.
This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.